Episode
DTRA’s Craig Lipset on Decentralized Trials and Accelerating Rare Disease Research
- Podcast
- from Dreamers to Disruptors
- Published
- Jul 13, 2026
- Duration seconds
- 3954
- Processing state
not_requested- Canonical source
- https://rss.com/podcasts/from-dreamers-to-disruptors/2985218
Actions
POST https://stenobird.com/v1/public/podcasts/from-dreamers-to-disruptors-7329003/episodes/dtra-s-craig-lipset-on-decentralized-trials-and-accelerating-rare-disease-research/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003/dtra-s-craig-lipset-on-decentralized-trials-and-accelerating-rare-disease-research.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
New technologies have always driven advances in clinical research, and that’s still true today. The Covid pandemic rapidly accelerated the adoption of decentralized trials, powered by emerging health tech, but in less dramatic times, life sciences must find ways to ensure continued innovation. As an industry veteran and co-chair of the Digital Trials & Research Alliance (DTRA), Craig Lipset has a powerful perspective on the potential of emerging technologies, and how to successfully combat inertia and encourage adoption in clinical studies. He joins Medidata CEO Anthony Costello to explore the origins of decentralized trials, the potential of Virtual Twins, and how the Buffalo Initiative is promoting research into understudied rare diseases. Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Anthony: LinkedIn Follow Craig: LinkedIn